Navigation Links
Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
Date:6/14/2011

PHILADELPHIA, PA (June 14, 2011) On June 15, the Lymphoma Research Foundation (LRF), in collaboration with the John Theurer Cancer Center at Hackensack University Medical Center, will bring together lymphoma experts to discuss the latest practices in the diagnosis and management of lymphoma. This event is the final installation of LRF's 2010-2011 Philadelphia Lymphoma Rounds program, a continuing medical education (CME) series focused on the diagnosis and treatment of lymphoma patients.

"The Philadelphia Lymphoma Round Program is an opportunity for clinicians to better understand the latest lymphoma treatment advancements and apply these findings to their practice," said Anthony Mato, M.D., Program Chair and Lymphoma Attending at the John Theurer Cancer Center. "The treatment of lymphoma is rapidly changing, and we are committed to forums like this to keep the latest information accessible to physicians across the country."

The Lymphoma Rounds program provides a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by local lymphoma experts. The Philadelphia Lymphoma Rounds program is chaired by Stephen Schuster, M.D., Associate Professor of Medicine at the University of Pennsylvania.

"Lymphoma Rounds are an integral part of the Lymphoma Research Foundation's professional education services," said Brian Tomlinson, LRF's Chief Program Officer. "We are thrilled to work with the John Theurer Cancer Center for the final Philadelphia Lymphoma Rounds program of the 2010-2011 year, and to enable attendees to benefit from the collaboration of lymphoma experts from the leading Philadelphia-area institutions."

This program is free for healthcare professionals; however, pre-registration is required and available online. The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.5 AMA PRA Category I Credit.

Food and refreshments will be provided for all registered participants. The event will be held at the Philadelphia Westin Hotel, 99 South 17th Street, Philadelphia, PA. For additional information, please contact Max Mulcahy at the Lymphoma Research Foundation at mmulcahy@lymphoma.org or register for the event at www.lymphoma.org/PLR.

The Lymphoma Research Foundation is presenting this meeting in collaboration with the John Theurer Cancer Center, Cooper University Hospital, Fox Chase Cancer Center, Helen F. Graham Cancer Center, Thomas Jefferson University, and University of Pennsylvania, and Vita Medical Associates. The complete 2011-2012 Lymphoma Rounds program schedule will be available in the Fall.


'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Vaccine increases disease-free survival for follicular lymphoma patients
2. Could Dogs DNA Give Clues to Human Lymphoma?
3. Sniffing out lymphoma by turning dogs into humans
4. 2 proteins play key roles in Burkitts lymphoma
5. Gene Mutation Suggests New Treatment Target for Specific Lymphoma
6. Study Adds to Evidence That Rituximab Slows Lymphoma Symptoms
7. Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
8. New standards of care and novel treatment options for several forms of lymphoma unveiled
9. Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade
10. New lymphoma therapy may be more effective with fewer side effects
11. New mutation linked to non-Hodgkins lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... 2017 , ... Ecommerce sales have grown every year since the 1990’s, with ... The consequences of rapid innovation and growth are often neglected in the name of ... business and individual’s job to give something back to the planet that provides the ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
(Date:4/21/2017)... CITY, Utah (PRWEB) , ... April 21, 2017 ... ... of wilderness therapy treatment for adolescents and young adults, has kicked off its ... 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for Mental ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... ... April 21, 2017 , ... Alive for Wellness is ... overcome their mental health struggles. The Alive team uses advanced behavioral sciences treatment ... in dealing with a mental health struggle is based on 10 modalities of ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., ... case series to be presented at the 2017 National ... begins today and continues through April 22. Physicians will ... , used to assess risk for acute kidney injury ... heart failure (ADHF). Elevated levels of ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc. and ... started in 2016, in which Socionext extracts and ... The companies achieved initial results in reading ultrasound ... Artificial Brain SOINN. The results will be introduced ... April 19-21, at booths 4505 & 4507. ...
(Date:4/18/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded ... infections, will present preclinical data supporting the use of ... (MDR) Gram-negative infections at the 27th European Congress of ... in Vienna, Austria . ... "Our ongoing preclinical ...
Breaking Medicine Technology: